Braeuning, A. (2018). Mouse Hepatomas with Ha-ras and B-raf Mutations Differ in Mitogen-Activated Protein Kinase Signaling and Response to Constitutive Androstane Receptor Activation [Short Communication]. The American Society for Pharmacology and Experimental Therapeutics (ASPET).
Chicago Style (17th ed.) CitationBraeuning, A. Mouse Hepatomas with Ha-ras and B-raf Mutations Differ in Mitogen-Activated Protein Kinase Signaling and Response to Constitutive Androstane Receptor Activation [Short Communication]. The American Society for Pharmacology and Experimental Therapeutics (ASPET), 2018.
MLA (9th ed.) CitationBraeuning, A. Mouse Hepatomas with Ha-ras and B-raf Mutations Differ in Mitogen-Activated Protein Kinase Signaling and Response to Constitutive Androstane Receptor Activation [Short Communication]. The American Society for Pharmacology and Experimental Therapeutics (ASPET), 2018.